IDT at OTS | 20th Annual Meeting of the  Oligonucleotide Therapeutics Society (2024)

We can’t wait to see you at the OTS 2024! Stop by our table to speak with our experts about how IDT’s CRISPR genome editing and gene regulation solutions can help you to move your project forward.

Our CRISPR product portfolio includes a comprehensive set of tools, reagents, and services for all your genome editing needs, including discovery, preclinical research, and clinical applications.

Our gene expression portfolio includes ASOs, dsiRNAs, and miRNA inhibitors to enable you to achieve high potency and high specificity in your loss-of-function studies.

As your trusted partner, we're committed to providing you with the highest quality products and services to accelerate your research and bring your discoveries to life.

Poster presentation

End-to-End Tools for Interrogation of CRISPR-Cas Associated Genotoxicity
Morgan Sturgeon, PhD.
CRISPR Application Development Manager, IDT

Featured products

CRISPR Genome Editing Solutions for your discovery and therapeutic development studies
Achieve higher efficiency genome editing and avoid toxicity or innate immune responses with Alt-R™ products.

Gene regulation solutions for your research
Achieve increased potency and better specificity in loss-of-function studies using short oligos.